Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
ALNYLAM PHARMACEUTICALS, INC. has filed 1,677 SEC EDGAR filings since 09 Jul 2002

SEC filing history

Showing 951-975 of 1,000 matching filings.

Per page
25
Current page
39
4

PRIMARY DOCUMENT

Filing date
28 Jan 2015
Reporting date
26 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
28 Jan 2015
Reporting date
26 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
28 Jan 2015
Reporting date
22 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36407

FORM 8-K

Filing date
26 Jan 2015
Reporting date
20 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-185658

424B5

Filing date
21 Jan 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-185658

424B5

Filing date
20 Jan 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36407

8-K

Filing date
14 Jan 2015
Reporting date
08 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q/A File 001-36407

FORM 10-Q AMENDMENT NO. 1

Filing date
09 Jan 2015
Reporting date
31 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36407

8-K

Filing date
08 Jan 2015
Reporting date
08 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
05 Jan 2015
Reporting date
31 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
22 Dec 2014
Reporting date
19 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36407

8-K

Filing date
19 Dec 2014
Reporting date
17 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Dec 2014
Reporting date
17 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
18 Dec 2014
Reporting date
17 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36407

8-K

Filing date
18 Dec 2014
Reporting date
17 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
16 Dec 2014
Reporting date
12 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
16 Dec 2014
Reporting date
12 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
16 Dec 2014
Reporting date
12 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
16 Dec 2014
Reporting date
12 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
16 Dec 2014
Reporting date
12 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
10 Dec 2014
Reporting date
08 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
10 Dec 2014
Reporting date
08 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
19 Nov 2014
Reporting date
18 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
19 Nov 2014
Reporting date
17 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
13 Nov 2014
Reporting date
11 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .